# Progesterone in Luteal Phase Deficiency

> **NCT02950948** · PHASE3 · WITHDRAWN · sponsor: **IBSA Institut Biochimique SA**

## Conditions studied

- Luteal Phase Defect

## Interventions

- **DRUG:** Progesterone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02950948
- **Lead sponsor:** IBSA Institut Biochimique SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-05-03
- **Primary completion:** 2019-03
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** inability to recruit an adequate number of subjects.
- **Last updated:** 2017-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02950948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02950948, "Progesterone in Luteal Phase Deficiency". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02950948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*